J&J Loses Dutch Stent Trial Against Boston Scientific

Law360, New York (October 14, 2005, 12:00 AM EDT) -- Johnson & Johnson will have to stop selling certain drug-coated stents in the Netherlands after rival medical device maker Boston Scientific prevailed in the latest chapter of the companies’ extensive litigation.

Boston Scientific sued J&J’s Netherlands-based subsidiary Cordis in Dutch court, asserting its patents for a balloon mechanism used to inflate certain stents.

The companies have been litigating over the medical devices for several years, vying for a bigger share of the $6 billion worldwide market for drug-coated stents.

So far, the infringement suits in the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.